Olanzapine: A proarrhythmic drug? [2]

Canadian Journal of Psychiatry

Volumn 47, Issue 7, 2002, Pages 683-684

  Gupta, Nitin ^a   Malhotra, Pankaj ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA; CLOZAPINE; ENALAPRIL MALEATE; IPRATROPIUM BROMIDE; LEVODOPA; OLANZAPINE; RISPERIDONE; SALBUTAMOL; THEOPHYLLINE; TRAMADOL;

AGED; ASTHMA; CASE REPORT; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; LETTER; OSTEOARTHRITIS; PARKINSON DISEASE; QT INTERVAL; QT PROLONGATION;

EID: 0036751170     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370204700717     Document Type: Letter

References (5)

1. Yap YG, Camm J. Risk of torsades de pointes with non-cardiac drugs. BMJ 2000;320:1158-9.
2. Wirshing DA, Erhart SM, Pierre JM, Boyd JA. Nonextrapyramidal side effects of novel antipsychotics. Curr Opin Psychiatry 2000;13:45-50.
3. Arun P, Gupta N. Symptomatic bradycardia: an adverse event following risperidone initiation in an elderly male. Hong Kong J Psychiatry 2001;11 (3):21-2.
4. Drici MD, Wang WX, Liu XK, Woosley RL, Flockhart DA. Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. J Clin Psychopharmacol 1998;18:477-81.
5. Karalliedde L, Henry J. Handbook of drug interactions. London: Arnold; 1998.